← Back to Search

Other

Mail-In Semen Analysis Kit for Male Infertility (EXPLORE Trial)

N/A

Recruiting

Led By Yanett Anaya, M.D.

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

All English or Spanish speaking male partners of female patients undergoing an infertility work-up evaluation at Zuckerberg San Francisco General Hospital and recommended to undergo a semen analysis as a part of this workup.

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up three months after being consented to the study.

Awards & highlights

EXPLORE Trial Summary

This trial is looking at the reasons why men don't finish their fertility evaluation, which is important to understand so that all aspects of infertility can be addressed in treatment. COVID-19 has made it especially hard for low-income communities to access medical care, so this trial is important for those affected by the pandemic.

Who is the study for?

This study is for English or Spanish speaking male partners of women undergoing infertility evaluations at Zuckerberg San Francisco General Hospital, who are recommended to have a semen analysis. Men must be over 18 years old and able to produce a semen sample.Check my eligibility

What is being tested?

The trial is testing the use of mail-in semen analysis kits as part of the male infertility evaluation process, especially aimed at improving access in low-resourced settings affected by COVID-19.See study design

What are the potential side effects?

Since this intervention involves only providing a semen sample using a kit, there are no direct medical side effects associated with it.

EXPLORE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a male partner of a patient at Zuckerberg San Francisco General Hospital, advised to have a semen analysis.

EXPLORE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months after consented to the study.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months after consented to the study.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after consented to the study. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

To compare the time to complete the semen analysis with in-clinic versus at-home testing.

Secondary outcome measures

To compare barriers unique to completing an in-clinic versus at-home testing.

To compare satisfaction scores with in-clinic versus at-home testing.

To compare the time to initiating treatment after completing in-clinic versus at-home testing.

+1 more

EXPLORE Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: No in-clinic semen analysis testingExperimental Treatment1 Intervention

Men needing semen analysis for infertility work-up.

Group II: In-Clinic Semen Analysis TestingActive Control1 Intervention

Men needing semen analysis for infertility work-up.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor

2,512 Previous Clinical Trials

15,244,304 Total Patients Enrolled

Yanett Anaya, M.D.Principal InvestigatorUniversity of California, San Francisco

Media Library

Mail-in semen analysis kit (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05205733 — N/A

Healthy Subjects Research Study Groups: In-Clinic Semen Analysis Testing, No in-clinic semen analysis testing

Healthy Subjects Clinical Trial 2023: Mail-in semen analysis kit Highlights & Side Effects. Trial Name: NCT05205733 — N/A

Mail-in semen analysis kit (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05205733 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I qualify to join this experiment?

"This study is recruiting 60 males aged 18 to 64 who are experiencing sterility. Crucially, applicants must meet the following conditions: they must be English- or Spanish-speaking male partners of female patients undergoing an infertility workup at Zuckerberg San Francisco General Hospital and recommended for semen analysis as part of that evaluation."

Answered by AI

Does this clinical trial encompass individuals who are elderly?

"Patients over 18 years of age and under 64 are eligible to partake in this medical investigation."

Answered by AI

Is it currently possible to enroll in this research project?

"The clinical trial is currently open for enrollment, as indicated on clinicaltrials.gov. It was initially advertised on May 24th 2022 and the last update posted to the site was June 1st 2022."

Answered by AI

How many participants are actively involved in the clinical trial?

"Affirmative. The details on clinicaltrials.gov demonstrate that this medical trial, which was first posted on May 24th 2022, is currently recruiting. Approximately 60 participants are required from one healthcare facility."

Answered by AI